Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Abstract Background No consensus treatment has been reached for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial chemoembolization (TACE) have been recommended as effective options, but which is better remains unclear. This meta-analysis...

Descripció completa

Dades bibliogràfiques
Autors principals:	Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng
Format:	Article
Idioma:	English
Publicat:	BMC 2017-12-01
Col·lecció:	BMC Cancer
Matèries:	Hepatic resection Transarterial chemoembolization Hepatocellular carcinoma Portal vein tumor thrombus
Accés en línia:	http://link.springer.com/article/10.1186/s12885-017-3895-z

Ítems similars

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
per: Lv WF, et al.
Publicat: (2018-10-01)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
per: Junwei Chen, et al.
Publicat: (2023-07-01)

Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
per: Ran You, et al.
Publicat: (2024-09-01)

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
per: Danbi Lee, et al.
Publicat: (2018-06-01)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
per: Won-Gyom Choe, et al.
Publicat: (2018-01-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
per: Yashwant Patidar, et al.
Publicat: (2021-04-01)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
per: Xiaomi Li, et al.
Publicat: (2023-08-01)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
per: Fangzhou Luo, et al.
Publicat: (2021-09-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
per: Fei-Xiang Wu, et al.
Publicat: (2017-09-01)

Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis
per: Zi-Han Zhang, et al.
Publicat: (2023-01-01)

Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
per: Ling Li, et al.
Publicat: (2022-02-01)

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
per: Jin-Kai Feng, et al.
Publicat: (2022-11-01)

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts
per: Xia WL, et al.
Publicat: (2024-09-01)

Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus
per: Yu Zhang, et al.
Publicat: (2022-01-01)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
per: Moon Haeng Hur, et al.
Publicat: (2023-07-01)

Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus
per: Aoran Dong, et al.
Publicat: (2023-12-01)

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
per: Li SQ, et al.
Publicat: (2023-10-01)

Comparison of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization versus transarterial chemoembolization and portal vein embolization for planned hepatectomy with insufficient future liver remnant
per: Tai-Wei Ye, et al.
Publicat: (2024-08-01)

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
per: Xiao-Hui Zhao, et al.
Publicat: (2022-10-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
per: Su Jong Yu, et al.
Publicat: (2023-03-01)

Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis
per: Jia Deng, et al.
Publicat: (2023-01-01)

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
per: Huang Q, et al.
Publicat: (2020-09-01)

DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
per: Junwei Chen, et al.
Publicat: (2022-11-01)

Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
per: Saikang Tang, et al.
Publicat: (2024-07-01)

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
per: Jiwon Yang, et al.
Publicat: (2024-09-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
per: You-Bin Wang, et al.
Publicat: (2023-09-01)

Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
per: Zhao XH, et al.
Publicat: (2023-02-01)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
per: Shuling Chen, et al.
Publicat: (2019-04-01)

Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
per: Jin Hyoung Kim, et al.
Publicat: (2024-10-01)

A Rare Case of Empyema Developed after Transarterial Chemoembolization for Hepatocellular Carcinoma
per: Young Keun Sur, et al.
Publicat: (2015-01-01)

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
per: Hiroki Higashihara, et al.
Publicat: (2021-10-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
per: Al Fuhaid Turki, et al.
Publicat: (2007-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
per: Zhang W, et al.
Publicat: (2021-07-01)

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
per: Xiaodong Song, et al.
Publicat: (2020-08-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
per: B. I. Dolgushin, et al.
Publicat: (2016-09-01)

Transileocolic Vein Obliteration for Bleeding Rectal Varices with Portal Thrombus
per: Hirotaka Arai, et al.
Publicat: (2013-03-01)

A combination of portal vein stent insertion and endovascular iodine-125 seed-strip implantation, followed by transcatheter arterial chemoembolization with sorafenib for treatment of hepatocellular carcinoma-associated portal vein tumor thrombus
per: Shuangxi Li, et al.
Publicat: (2021-12-01)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
per: Zheng Y, et al.
Publicat: (2024-06-01)

Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma
per: Hongfa Sun, et al.
Publicat: (2023-03-01)

Survival Benefit of Transarterial Chemoembolization for Hepatocellular Carcinoma
per: Waqas Ahmad, et al.
Publicat: (2020-06-01)